A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy

Purpose Multimodality treatments combining radiotherapy, immune therapy and/or targeted therapy are under heavy investigation. Promising data from clinical trials are emerging, nevertheless unexpected interactions and adverse events should not be overlooked. Case presentation Here we present a case...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical journal of gastroenterology 2021-08, Vol.14 (4), p.1121-1125
Hauptverfasser: Orazem, Miha, Draulans, Cédric, Spaas, Mathieu, Van Cutsem, Eric, Debecker, Marina, De Meerleer, Gert, Tejpar, Sabine, Dekervel, Jeroen, Haustermans, Karin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1125
container_issue 4
container_start_page 1121
container_title Clinical journal of gastroenterology
container_volume 14
creator Orazem, Miha
Draulans, Cédric
Spaas, Mathieu
Van Cutsem, Eric
Debecker, Marina
De Meerleer, Gert
Tejpar, Sabine
Dekervel, Jeroen
Haustermans, Karin
description Purpose Multimodality treatments combining radiotherapy, immune therapy and/or targeted therapy are under heavy investigation. Promising data from clinical trials are emerging, nevertheless unexpected interactions and adverse events should not be overlooked. Case presentation Here we present a case study of a patient with metastatic colon adenocarcinoma treated sequentially with a chemotherapy/targeted therapy combination, immune checkpoint inhibitors and ultra-hypofractionated radiotherapy. After radiation treatment, the patient developed extensive posterior abdominal wall wounds coinciding with regression of the irradiated metastatic tumour mass and marked elevation of the inflammation parameters. Conclusion This case represents an unusual fatal wound complication after palliative ultra-hypofractionated radiotherapy. Further research into synergistic effects of sequential radiotherapy and anti-angiogenesis therapy may provide an advantage in anticipating severe sequelae.
doi_str_mv 10.1007/s12328-021-01399-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2511895390</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2511895390</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-fced3ee3ad16911b115d20e6df674e6bf04d21282b15ac897703c58797c40d893</originalsourceid><addsrcrecordid>eNp9kctu3CAUhlHVqLm0L9BFxLKL0nAxxl5GUZpEitRNu0YYjmdIbHAAK5on6GuXZCZZdnUQfOeTfn6EvjL6g1GqLjLjgneEckYoE31P-Ad0wrpWEsVb-fH9LNUxOs35gdKWUyU-oWMhuqZhvDtBfy_xaIqZ8HNcg8M2zsvkrSk-BjzGaYrPPmxwhqcVQvGVM3UQEzY-biBA9vk79vO8BsB2C_ZxiT4U7MPWD_5VYqp1nUoyZLtb4piMfbk2BRxOxvlYtpDMsvuMjkYzZfhymGfoz8_r31e35P7Xzd3V5T2xDZOFjBacABDGsbZnbGBMOk6hdWOrGmiHkTaO12B8YNLYrleKCis71SvbUNf14gx923uXFGumXPTss4VpMgHimjWXjHW9FD2tKN-jNsWcE4x6SX42aacZ1S8F6H0BuhagXwvQvC6dH_zrMIN7X3n78QqIPZDrU9hA0g9xTaFm_p_2H0UJlL4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2511895390</pqid></control><display><type>article</type><title>A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Orazem, Miha ; Draulans, Cédric ; Spaas, Mathieu ; Van Cutsem, Eric ; Debecker, Marina ; De Meerleer, Gert ; Tejpar, Sabine ; Dekervel, Jeroen ; Haustermans, Karin</creator><creatorcontrib>Orazem, Miha ; Draulans, Cédric ; Spaas, Mathieu ; Van Cutsem, Eric ; Debecker, Marina ; De Meerleer, Gert ; Tejpar, Sabine ; Dekervel, Jeroen ; Haustermans, Karin</creatorcontrib><description>Purpose Multimodality treatments combining radiotherapy, immune therapy and/or targeted therapy are under heavy investigation. Promising data from clinical trials are emerging, nevertheless unexpected interactions and adverse events should not be overlooked. Case presentation Here we present a case study of a patient with metastatic colon adenocarcinoma treated sequentially with a chemotherapy/targeted therapy combination, immune checkpoint inhibitors and ultra-hypofractionated radiotherapy. After radiation treatment, the patient developed extensive posterior abdominal wall wounds coinciding with regression of the irradiated metastatic tumour mass and marked elevation of the inflammation parameters. Conclusion This case represents an unusual fatal wound complication after palliative ultra-hypofractionated radiotherapy. Further research into synergistic effects of sequential radiotherapy and anti-angiogenesis therapy may provide an advantage in anticipating severe sequelae.</description><identifier>ISSN: 1865-7257</identifier><identifier>EISSN: 1865-7265</identifier><identifier>DOI: 10.1007/s12328-021-01399-2</identifier><identifier>PMID: 33844128</identifier><language>eng</language><publisher>Singapore: Springer Singapore</publisher><subject>Abdominal Surgery ; Case Report ; Colorectal Surgery ; Combined Modality Therapy ; Gastroenterology ; Hepatology ; Humans ; Immune Checkpoint Inhibitors ; Immunotherapy ; Medicine ; Medicine &amp; Public Health ; Surgical Oncology</subject><ispartof>Clinical journal of gastroenterology, 2021-08, Vol.14 (4), p.1121-1125</ispartof><rights>Japanese Society of Gastroenterology 2021</rights><rights>2021. Japanese Society of Gastroenterology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-fced3ee3ad16911b115d20e6df674e6bf04d21282b15ac897703c58797c40d893</citedby><cites>FETCH-LOGICAL-c415t-fced3ee3ad16911b115d20e6df674e6bf04d21282b15ac897703c58797c40d893</cites><orcidid>0000-0002-1267-7874</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12328-021-01399-2$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12328-021-01399-2$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33844128$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Orazem, Miha</creatorcontrib><creatorcontrib>Draulans, Cédric</creatorcontrib><creatorcontrib>Spaas, Mathieu</creatorcontrib><creatorcontrib>Van Cutsem, Eric</creatorcontrib><creatorcontrib>Debecker, Marina</creatorcontrib><creatorcontrib>De Meerleer, Gert</creatorcontrib><creatorcontrib>Tejpar, Sabine</creatorcontrib><creatorcontrib>Dekervel, Jeroen</creatorcontrib><creatorcontrib>Haustermans, Karin</creatorcontrib><title>A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy</title><title>Clinical journal of gastroenterology</title><addtitle>Clin J Gastroenterol</addtitle><addtitle>Clin J Gastroenterol</addtitle><description>Purpose Multimodality treatments combining radiotherapy, immune therapy and/or targeted therapy are under heavy investigation. Promising data from clinical trials are emerging, nevertheless unexpected interactions and adverse events should not be overlooked. Case presentation Here we present a case study of a patient with metastatic colon adenocarcinoma treated sequentially with a chemotherapy/targeted therapy combination, immune checkpoint inhibitors and ultra-hypofractionated radiotherapy. After radiation treatment, the patient developed extensive posterior abdominal wall wounds coinciding with regression of the irradiated metastatic tumour mass and marked elevation of the inflammation parameters. Conclusion This case represents an unusual fatal wound complication after palliative ultra-hypofractionated radiotherapy. Further research into synergistic effects of sequential radiotherapy and anti-angiogenesis therapy may provide an advantage in anticipating severe sequelae.</description><subject>Abdominal Surgery</subject><subject>Case Report</subject><subject>Colorectal Surgery</subject><subject>Combined Modality Therapy</subject><subject>Gastroenterology</subject><subject>Hepatology</subject><subject>Humans</subject><subject>Immune Checkpoint Inhibitors</subject><subject>Immunotherapy</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Surgical Oncology</subject><issn>1865-7257</issn><issn>1865-7265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kctu3CAUhlHVqLm0L9BFxLKL0nAxxl5GUZpEitRNu0YYjmdIbHAAK5on6GuXZCZZdnUQfOeTfn6EvjL6g1GqLjLjgneEckYoE31P-Ad0wrpWEsVb-fH9LNUxOs35gdKWUyU-oWMhuqZhvDtBfy_xaIqZ8HNcg8M2zsvkrSk-BjzGaYrPPmxwhqcVQvGVM3UQEzY-biBA9vk79vO8BsB2C_ZxiT4U7MPWD_5VYqp1nUoyZLtb4piMfbk2BRxOxvlYtpDMsvuMjkYzZfhymGfoz8_r31e35P7Xzd3V5T2xDZOFjBacABDGsbZnbGBMOk6hdWOrGmiHkTaO12B8YNLYrleKCis71SvbUNf14gx923uXFGumXPTss4VpMgHimjWXjHW9FD2tKN-jNsWcE4x6SX42aacZ1S8F6H0BuhagXwvQvC6dH_zrMIN7X3n78QqIPZDrU9hA0g9xTaFm_p_2H0UJlL4</recordid><startdate>20210801</startdate><enddate>20210801</enddate><creator>Orazem, Miha</creator><creator>Draulans, Cédric</creator><creator>Spaas, Mathieu</creator><creator>Van Cutsem, Eric</creator><creator>Debecker, Marina</creator><creator>De Meerleer, Gert</creator><creator>Tejpar, Sabine</creator><creator>Dekervel, Jeroen</creator><creator>Haustermans, Karin</creator><general>Springer Singapore</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1267-7874</orcidid></search><sort><creationdate>20210801</creationdate><title>A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy</title><author>Orazem, Miha ; Draulans, Cédric ; Spaas, Mathieu ; Van Cutsem, Eric ; Debecker, Marina ; De Meerleer, Gert ; Tejpar, Sabine ; Dekervel, Jeroen ; Haustermans, Karin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-fced3ee3ad16911b115d20e6df674e6bf04d21282b15ac897703c58797c40d893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Abdominal Surgery</topic><topic>Case Report</topic><topic>Colorectal Surgery</topic><topic>Combined Modality Therapy</topic><topic>Gastroenterology</topic><topic>Hepatology</topic><topic>Humans</topic><topic>Immune Checkpoint Inhibitors</topic><topic>Immunotherapy</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Surgical Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Orazem, Miha</creatorcontrib><creatorcontrib>Draulans, Cédric</creatorcontrib><creatorcontrib>Spaas, Mathieu</creatorcontrib><creatorcontrib>Van Cutsem, Eric</creatorcontrib><creatorcontrib>Debecker, Marina</creatorcontrib><creatorcontrib>De Meerleer, Gert</creatorcontrib><creatorcontrib>Tejpar, Sabine</creatorcontrib><creatorcontrib>Dekervel, Jeroen</creatorcontrib><creatorcontrib>Haustermans, Karin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical journal of gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Orazem, Miha</au><au>Draulans, Cédric</au><au>Spaas, Mathieu</au><au>Van Cutsem, Eric</au><au>Debecker, Marina</au><au>De Meerleer, Gert</au><au>Tejpar, Sabine</au><au>Dekervel, Jeroen</au><au>Haustermans, Karin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy</atitle><jtitle>Clinical journal of gastroenterology</jtitle><stitle>Clin J Gastroenterol</stitle><addtitle>Clin J Gastroenterol</addtitle><date>2021-08-01</date><risdate>2021</risdate><volume>14</volume><issue>4</issue><spage>1121</spage><epage>1125</epage><pages>1121-1125</pages><issn>1865-7257</issn><eissn>1865-7265</eissn><abstract>Purpose Multimodality treatments combining radiotherapy, immune therapy and/or targeted therapy are under heavy investigation. Promising data from clinical trials are emerging, nevertheless unexpected interactions and adverse events should not be overlooked. Case presentation Here we present a case study of a patient with metastatic colon adenocarcinoma treated sequentially with a chemotherapy/targeted therapy combination, immune checkpoint inhibitors and ultra-hypofractionated radiotherapy. After radiation treatment, the patient developed extensive posterior abdominal wall wounds coinciding with regression of the irradiated metastatic tumour mass and marked elevation of the inflammation parameters. Conclusion This case represents an unusual fatal wound complication after palliative ultra-hypofractionated radiotherapy. Further research into synergistic effects of sequential radiotherapy and anti-angiogenesis therapy may provide an advantage in anticipating severe sequelae.</abstract><cop>Singapore</cop><pub>Springer Singapore</pub><pmid>33844128</pmid><doi>10.1007/s12328-021-01399-2</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-1267-7874</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1865-7257
ispartof Clinical journal of gastroenterology, 2021-08, Vol.14 (4), p.1121-1125
issn 1865-7257
1865-7265
language eng
recordid cdi_proquest_miscellaneous_2511895390
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Abdominal Surgery
Case Report
Colorectal Surgery
Combined Modality Therapy
Gastroenterology
Hepatology
Humans
Immune Checkpoint Inhibitors
Immunotherapy
Medicine
Medicine & Public Health
Surgical Oncology
title A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T15%3A07%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20fatal%20wound%20complication%20following%20sequential%20anti-angiogenesis,%20immune%20checkpoint%20inhibition%20and%20ultra-hypofractionated%20radiotherapy&rft.jtitle=Clinical%20journal%20of%20gastroenterology&rft.au=Orazem,%20Miha&rft.date=2021-08-01&rft.volume=14&rft.issue=4&rft.spage=1121&rft.epage=1125&rft.pages=1121-1125&rft.issn=1865-7257&rft.eissn=1865-7265&rft_id=info:doi/10.1007/s12328-021-01399-2&rft_dat=%3Cproquest_cross%3E2511895390%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2511895390&rft_id=info:pmid/33844128&rfr_iscdi=true